Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

April
27
2026

Basal Cell Carcinoma vs. Squamous Cell Carcinoma: What’s the Difference?

Melanoma and non-melanoma are two primary categories of skin cancer. Each presents different symptoms and treatment options. Within the non-melanoma skin cancer – sometimes referred to as NMSC – category, the two most common types…

June
14
2017

The SRT-100™: Non-Invasive Basal Cell Carcinoma Treatment

While Mohs surgery has proven to be extremely effective at treating non-melanoma skin cancers like basal cell carcinoma and squamous cell carcinoma, there are huge drawbacks to the procedure from the perspective of the patient….

June
05
2017

Sensus to Present at the 2017 Marcum MicroCap Conference

  BOCA RATON, Fla., June 05, 2017 — Sensus Healthcare, Inc. (Nasdaq:SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids, with superficial radiation therapy (SRT), today announced Joe…

May
30
2017

This Boca Raton company was named South Florida’s most ‘disruptive’

The Greater Miami Chamber of Commerce has named medical device company Sensus Healthcare the most “disruptive” technology startup for 2017. Boca Raton-based Sensus Healthcare specializes in non-invasive tools aimed at treating skin conditions, such as…

May
24
2017

Sensus Healthcare Awarded 2017 Technology Leader of the Year for Disruptive Technology from Greater Miami Chamber of Commerce

BOCA RATON, Fla., May 24, 2017 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers (NMSC) and other skin conditions, such as keloids with Superficial Radiotherapy…

Archives
Archives

IN THE NEWS

CEO Joseph Sardano on Coding for Superficial Radiation Therapy